The impact of discontinuing methylphenidate on weight and eating behavior
Uložené v:
| Názov: | The impact of discontinuing methylphenidate on weight and eating behavior |
|---|---|
| Autori: | Benard, Victoire, Cottencin, Olivier, Guardia, Dewi, Vaiva, Guillaume, Rolland, Benjamin |
| Prispievatelia: | Université de Lille, LillOA |
| Zdroj: | International Journal of Eating Disorders. 48:345-348 |
| Informácie o vydavateľovi: | Wiley, 2014. |
| Rok vydania: | 2014 |
| Predmety: | Male, Adolescent, methylphenidate, eating disorders, amphetamines, Weight Gain, 7. Clean energy, Body Mass Index, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Humans, Central Nervous System Stimulants/therapeutic use, 2. Zero hunger, attention deficit disorder with hyperactivity, weight gain, Feeding Behavior/drug effects, [SCCO] Cognitive science, Feeding Behavior, Methylphenidate/therapeutic use, drug toxicity, 3. Good health, [SDV] Life Sciences [q-bio], Weight Gain/drug effects, Attention Deficit Disorder with Hyperactivity, pharmacovigilance, Methylphenidate, Attention Deficit Disorder with Hyperactivity/drug therapy, Central Nervous System Stimulants |
| Popis: | Chronic administration of the amphetamine‐derivative methylphenidate (MPH) may induce appetite reduction and weight loss. By contrast, the effects that stopping chronic MPH may exert on eating behavior and body weight are poorly known.We report the case of a male patient with childhood attention deficit/hyperactivity disorder (ADHD), who discontinued MPH treatment at the age of 11 years and was lost to follow‐up until the age of 16. The patient's body mass index increased by five points within 1 year of MPH cessation while the symptoms of ADHD were re‐emerging. The patient secondarily developed DSM‐5 criteria for eating disorders.Discontinuing chronic MPH can significantly affect weight and eating behavior. Such risks should warrant further studies, as they could be particularly increased in patients with ADHD, who share common vulnerability factors with both obesity and eating disorders. © 2014 Wiley Periodicals, Inc. (Int J Eat Disord 2015; 48:345–348) |
| Druh dokumentu: | Article |
| Jazyk: | English |
| ISSN: | 1098-108X 0276-3478 |
| DOI: | 10.1002/eat.22301 |
| Prístupová URL adresa: | https://pubmed.ncbi.nlm.nih.gov/24849706 https://lilloa.univ-lille.fr/handle/20.500.12210/15941 https://onlinelibrary.wiley.com/doi/full/10.1002/eat.22301 https://www.cabdirect.org/cabdirect/abstract/20153124020 https://pubmed.ncbi.nlm.nih.gov/24849706/ https://www.onlinelibrary.wiley.com/doi/pdf/10.1002/eat.22301 https://www.ncbi.nlm.nih.gov/pubmed/24849706 |
| Rights: | Wiley Online Library User Agreement |
| Prístupové číslo: | edsair.doi.dedup.....f98f8228799e305bb7acfdf79952b2a5 |
| Databáza: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstrakt: | Chronic administration of the amphetamine‐derivative methylphenidate (MPH) may induce appetite reduction and weight loss. By contrast, the effects that stopping chronic MPH may exert on eating behavior and body weight are poorly known.We report the case of a male patient with childhood attention deficit/hyperactivity disorder (ADHD), who discontinued MPH treatment at the age of 11 years and was lost to follow‐up until the age of 16. The patient's body mass index increased by five points within 1 year of MPH cessation while the symptoms of ADHD were re‐emerging. The patient secondarily developed DSM‐5 criteria for eating disorders.Discontinuing chronic MPH can significantly affect weight and eating behavior. Such risks should warrant further studies, as they could be particularly increased in patients with ADHD, who share common vulnerability factors with both obesity and eating disorders. © 2014 Wiley Periodicals, Inc. (Int J Eat Disord 2015; 48:345–348) |
|---|---|
| ISSN: | 1098108X 02763478 |
| DOI: | 10.1002/eat.22301 |